Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing

Improved systems for detection of measurable residual disease (MRD) in acute myeloid leukemia (AML) are urgently needed, however attempts to utilize broad-scale next-generation sequencing (NGS) panels to perform multi-gene surveillance in AML post-induction have been stymied by persistent premaligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Balagopal, Vidya, Hantel, Andrew, Kadri, Sabah, Steinhardt, George, Zhen, Chao Jie, Kang, Wenjun, Wanjari, Pankhuri, Ritterhouse, Lauren L., Stock, Wendy, Segal, Jeremy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816574/
https://www.ncbi.nlm.nih.gov/pubmed/31658273
http://dx.doi.org/10.1371/journal.pone.0224097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816574/
https://www.ncbi.nlm.nih.gov/pubmed/31658273
http://dx.doi.org/10.1371/journal.pone.0224097

Ejemplares similares